Palexia (Tapentadol)

Tapentadol, the active ingredient in Palexia, is an opioid analgesic presented as a strength/form for oral use. It is indicated for the management of moderate to severe acute pain in adults.

GNH USA supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Tapentadol is an opioid analgesic that acts on the central nervous system to relieve pain. It is used in the following clinical situations: - Acute postoperative pain: Provides effective analgesia following surgical procedures. - Cancer‑related pain: Helps alleviate moderate to severe pain associated with malignancies. - Chronic musculoskeletal pain: Reduces pain intensity in conditions such as osteoarthritis and low back pain.

Tapentadol may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Nausea - Dizziness - Constipation - Headache - Somnolence - Dry mouth

Serious or Rare Side Effects: - Respiratory depression - Seizures - Severe hypotension - Allergic reactions such as angio‑edema - Serotonin syndrome (when combined with serotonergic drugs) - Dependence or withdrawal syndrome

When prescribing Tapetadol, clinicians should consider several safety aspects: - Assess patient history: Review the risk of abuse and addiction before initiating therapy. - Monitor renal and hepatic function: Adjust dosage if impair the liver or kidney . - Concomitant CNS‑active drugs :   - Caution   tt  t   t  ewline - Use  ewline

t  ewline   ewline  ewline -   ewline  ewline t  ewline  ewline  \n-  ewline  ewline  ewline  ewline  ewline -  bsp  ewline lank  ewline  ewline -  ewline -  ewline - Store at below 25°C: keep the original pack and protect from moisture.

The       ewline  ewline  ewline ... 

   ewline  """"  ""  """ "" \